Oxford University Press to publish Diseases of the Esophagus
(Oxford University Press USA) Oxford University Press and the International Society for Diseases of the Esophagus (ISDE) are pleased to announce their new partnership to publish Diseases of the Esophagus, ISDE's monthly scientific journal. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 30, 2017 Category: Cancer & Oncology Source Type: news

Breath test could help detect stomach and esophageal cancers
A test that measures the levels of five chemicals in the breath has shown promising results for the detection of cancers of the oesophagus and stomach in a large patient trial. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 30, 2017 Category: Science Source Type: news

Breath test may be key to early diagnosis of stomach and oesophageal cancers
A SIMPLE breath test could soon be used to diagnose early cases of two deadly cancers. (Source: Daily Express - Health)
Source: Daily Express - Health - January 30, 2017 Category: Consumer Health News Source Type: news

Breath test shows potential for detecting cancer
Conclusion This study aimed to see whether a breath test could be used to detect stomach and oesophageal cancers. The researchers found that the breath test was fairly accurate in distinguishing between those with and without cancer. The lead researcher, Dr Markar, said: "Because cancer cells are different to healthy ones, they produce a different mixture of chemicals. This study suggests that we may be able detect these differences and use a breath test to indicate which patients are likely to have cancer of the oesophagus and stomach, and which do not." However he went on to say that the findings of this study ...
Source: NHS News Feed - January 30, 2017 Category: Consumer Health News Tags: Cancer Source Type: news

Breath test could help detect stomach and oesophageal cancers
(ECCO-the European CanCer Organisation) A test that measures the levels of five chemicals in the breath has shown promising results for the detection of cancers of the oesophagus and stomach, according to research presented at the European Cancer Congress 2017. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 29, 2017 Category: Global & Universal Source Type: news

Breath test could help detect stomach and esophageal cancers
(ECCO-the European CanCer Organisation) A test that measures the levels of five chemicals in the breath has shown promising results for the detection of cancers of the esophagus and stomach, according to research presented at the European Cancer Congress 2017. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 29, 2017 Category: Cancer & Oncology Source Type: news

Depression and Anxiety Tied to Cancer Deaths
The associations were particularly strong for colon and rectal, prostate, pancreatic and esophageal cancers, and for leukemia. (Source: NYT Health)
Source: NYT Health - January 27, 2017 Category: Consumer Health News Authors: NICHOLAS BAKALAR Tags: Anxiety and Stress Esophageal Cancer Leukemia Deaths (Fatalities) Colon and Colorectal Cancer Prostate Cancer Pancreatic Cancer Source Type: news

Anxiety and depression linked to increased cancer death risk
Conclusion Studies like this can be distressing for people with mental health difficulties and their families and friends. It's important to point out that having anxiety or depression, which are common illnesses, does not mean you will go on to get, or die from, cancer. It may be your risk of it higher, but cancer risk is complex. It includes many factors such as our genes, our environment and our lifestyle. We don't know from the study whether mental distress is a cause of cancer, or of cancer mortality. It could be a reflection of another confounding factor – for example, people with poor mental health may have a...
Source: NHS News Feed - January 26, 2017 Category: Consumer Health News Tags: Mental health Cancer Source Type: news

Esophageal Cancer -- Two Separate Diseases Esophageal Cancer -- Two Separate Diseases
Genomic study suggests esophageal squamous cell carcinoma and adenocarcinoma are separate diseases, which could lead to the development of new targeted therapies.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 23, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

PET-Guided Therapy Switch for Esophageal Cancer
(MedPage Today) -- Improved response with switch from ineffective treatment (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - January 19, 2017 Category: Gastroenterology Source Type: news

PET Scan to'Fine Tune' Chemo for Esophageal Cancer PET Scan to'Fine Tune' Chemo for Esophageal Cancer
Who wouldn't want to switch chemotherapies if one wasn't working? A new study shows that PET scans can guide this decision and improve efficacy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 18, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Immunotherapy Treatments Only Just Emerging in Esophageal, Gastric Cancers
Ahead of the 2017 ASCO Gastrointestinal Cancer Symposium in San Francisco, we spoke with Dr. Geoffrey Ku on the advances in systemic therapy for esophageal and gastric cancer. (Source: CancerNetwork)
Source: CancerNetwork - January 18, 2017 Category: Cancer & Oncology Authors: Geoffrey Ku, MD Tags: Conferences/ASCO 2017 Gastrointestinal Cancers Symposium Conference Report Esophageal Cancer Source Type: news

PET Scans Helped Tailor Induction Chemotherapy for Esophageal Cancers
Using PET scans during induction chemotherapy for esophageal cancer, researchers were able to assess patient response to treatment and adjust their therapy, leading to an improved rate of pathologic complete response prior to surgery. (Source: CancerNetwork)
Source: CancerNetwork - January 17, 2017 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Conferences/ASCO 2017 Gastrointestinal Cancers Symposium Esophageal Cancer News Source Type: news

First of its kind cancer stem cell research unlocks clues to treatment resistance
(Trinity College Dublin) Researchers at Trinity College Dublin have made exciting new findings that could offer a means of fighting resistance to treatment for people with esophageal cancer. Resistance to radiotherapy is a major stumbling block in the treatment of this cancer. For the first time, the research team have discovered that a molecule lost from cancer stem cells, called miR-17, is important in driving esophageal tumor resistance to radiotherapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 17, 2017 Category: Global & Universal Source Type: news

Vermont Governor Says His Dying Father Used State's Death-With-Dignity Law
Outgoing Vermont Gov. Peter Shumlin (D) revealed that his terminally sick father took advantage of the state’s aid-in-dying law about a year after he signed it. The legislation, passed nearly four years ago, allows patients who have been diagnosed with six months or less to live to choose to end their own lives with the help of their physician.  Shumlin, who decided against seeking re-election in 2016, spoke about his father’s death while detailing his legislative accomplishments in his farewell address on Wednesday. “Terminally ill patients can now make their end-of-life choices as they should ...
Source: Healthy Living - The Huffington Post - January 5, 2017 Category: Consumer Health News Source Type: news

Study sheds light on esophageal cancer, offers insight into increasingly common disease
(Van Andel Research Institute) A comprehensive analysis of 559 esophageal and gastric cancer samples, collected from patients around the world, suggests the two main types of esophageal cancer differ markedly in their molecular characteristics and should be considered separate diseases. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 4, 2017 Category: Cancer & Oncology Source Type: news

Low Progression Risk With Barrett's Esophagus Less Than 1 Cm Low Progression Risk With Barrett's Esophagus Less Than 1 Cm
The risk of progression to high-grade dysplasia (HGD) or esophageal adenocarcinoma (EAC) is very low among patients with Barrett's esophagus less than 1 cm, according to a new study.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - December 30, 2016 Category: Pathology Tags: Gastroenterology News Source Type: news

Genetic complexity of cancer cells within the same tumor
A new study dramatically illustrates the complexity of cancer by identifying more than 2,000 genetic mutations in tissue samples of esophageal tumors. The findings reveal that even different areas of individual tumors have various genetic patterns. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - December 28, 2016 Category: Science Source Type: news

Study unmasks the genetic complexity of cancer cells within the same tumor
(Cedars-Sinai Medical Center) A new study led by Cedars-Sinai investigators dramatically illustrates the complexity of cancer by identifying more than 2,000 genetic mutations in tissue samples of esophageal tumors. The findings reveal that even different areas of individual tumors have various genetic patterns. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 28, 2016 Category: Global & Universal Source Type: news

Blood pressure medication paves the way for approaches to managing Barrett's syndrome
New ways of using mechanisms behind certain blood pressure medications may, in the future, spare some patient groups both discomfort and lifelong concern over cancer of the esophagus. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - December 12, 2016 Category: Science Source Type: news

Blood pressure medication paves the way for approaches to managing Barrett's syndrome
(University of Gothenburg) New ways of using mechanisms behind certain blood pressure medications may in the future spare some patient groups both discomfort and lifelong concern over cancer of the esophagus. This, in any case, is the goal of several studies of patients with Barrett's syndrome at Sahlgrenska Academy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 12, 2016 Category: Cancer & Oncology Source Type: news

Oral bacterium related esophageal cancer prognosis in Japanese patients
(Kumamoto University) A type of bacterium usually found in the human mouth, Fusobacterium nucleatum (F. nucleatum), has been found to be related to the prognosis of esophageal cancer in Japanese patients by researchers from Kumamoto University, Japan. The bacteria are a causative agent of periodontal disease and though it can be found among the intestinal flora, it hasn't been the focus of much research until now. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 8, 2016 Category: Global & Universal Source Type: news

Extranodal Lymph Node Metastasis in Esophageal Cancer Extranodal Lymph Node Metastasis in Esophageal Cancer
This study aims to clarify the prognostic value of extranodal extension of nodal metastasis in patients with lymph node positive esophageal cancer. Should ENE be considered in staging?Journal of Clinical Pathology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 1, 2016 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Esophageal Cancer
Title: Esophageal CancerCategory: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 11/30/2016 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - November 30, 2016 Category: Cancer & Oncology Source Type: news

A World Without Cancer: The Real Promise Of Prevention
What do Ken Burns and Valerie Simpson have in common? They are both highly accomplished, creative and articulate individuals. They have also lost a parent a parent to cancer at a young age, and each of them has been profoundly influenced by that loss. Ken and Valerie share their stories in the PBS one-hour special program entitled, “A World Without Cancer: The Real Promise of Prevention,” which airs nationally at the end of November, 2016.  Scientific research tells us that over fifty percent of all cancer is preventable, and that is the good news that empowers us all to reduce our risk for cancer. “...
Source: Science - The Huffington Post - November 27, 2016 Category: Science Source Type: news

Macrocure Announces New Date for Special General Meeting of Shareholders to Approve Merger With Leap Therapeutics
PETACH TIKVA, Israel, November 25, 2016 -- (Healthcare Sales & Marketing Network) -- Macrocure Ltd. (MCUR), a clinical-stage biotechnology company, today announced that it has delayed the scheduled date for its previously-announced Special General Meeting... Biopharmaceuticals, Oncology, Mergers & Acquisitions Macrocure, Leap Therapeutics, monoclonal antibody, esophageal cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 25, 2016 Category: Pharmaceuticals Source Type: news

Alcohol and Cancer Trends - Intervention Scenarios
This report found that alcohol will cause around 135,000 cancer deaths over the next 20 years and cost the NHS around £ 2 billion in treatments. The report warns that oesophageal cancer is likely to increase most. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - November 22, 2016 Category: Consumer Health News Source Type: news

Athenex and Eli Lilly collaborate for Phase Ib cancer study of combination drug
Athenex and Eli Lilly have collaborated to conduct a Phase Ib study of oraxol and cyramza (ramucirumab) to treat patients with advanced gastric (stomach) and esophageal cancer. (Source: Drug Development Technology)
Source: Drug Development Technology - November 22, 2016 Category: Pharmaceuticals Source Type: news

Should you talk about having cancer?
BBC Radio 4's Steve Hewlett was diagnosed with cancer of the oesophagus, he discusses the pros and cons of talking openly about your condition. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - November 21, 2016 Category: Consumer Health News Source Type: news

Athenex, Lilly ink clinical collaboration for 1st oral formulation of paclitaxel
Athenex said today that it inked a clinical collaboration deal to conduct a phase Ib study for its oral form of paclitaxel, Oraxol, with Eli Lilly‘s (NYSE:LLY) vascular endothelial growth factor (VEGF) receptor 2 antagonist, Cyramza. Patients with advanced gastric and esophageal cancer will be enrolled in 2017 at sites in the U.S. and Asia, where Athenex will sponsor the trial and Lilly will supply Cyramza. Cyramza is approved in the U.S. for use as a monotherapy or in combination with paclitaxel as treatment for advanced or metastatic stomach cancers. Get the full story at our sister site, Drug Delivery Bu...
Source: Mass Device - November 18, 2016 Category: Medical Equipment Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Oncology Research & Development Athenex Eli Lilly & Co. Source Type: news

Nutty stimulant revealed as anticancer tool
Arecoline, a component in areca nuts, is analogous to nicotine, say scientists. Areca nuts are chewed for their stimulant effects in many Asian countries, and evidence links the practice to the development of oral and esophageal cancer. Analogous to nicotine, arecoline was identified as an inhibitor of the enzyme ACAT1, which contributes to the metabolism-distorting Warburg effect in cancer cells. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - November 17, 2016 Category: Science Source Type: news

How to Quit Smoking
By Stacy Simon Tobacco use remains the single largest preventable cause of disease and premature death in the United States. Since the release of the Surgeon General’s Report on Smoking and Health 50 years ago, there have been 20 million deaths due to tobacco. Almost half the deaths from 12 different types of cancer combined – including lung, voice box, throat, esophagus, and bladder cancers – are attributable to cigarette smoking alone. In addition to cancer, smoking greatly increases the risk of debilitating long-term lung diseases like emphysema and chronic bronchitis. It also raises the risk for heart...
Source: American Cancer Society :: News and Features - November 16, 2016 Category: Cancer & Oncology Tags: Smoking/Tobacco Source Type: news

Oral Thrush - What Bumps on Your Tongue May Be Telling You
Stick your tongue out and look in the mirror. A healthy tongue should be pink and slightly red, and covered with tiny nodules. An appearance with a white coating or bumps on the tongue are a deviation from your tongue's normal appearance and may be cause for concern. A minor infection on the tongue isn't uncommon. Bumps may even appear after an injury from a bite or irritation to some foods, for example hot foods. A canker sore is another common cause of pain on or under the tongue. But if you have large bumps at the back of your tongue, and a coating of white on your tongue it may be a sign of Oral Thrush. Oral thrush...
Source: Healthy Living - The Huffington Post - November 14, 2016 Category: Consumer Health News Source Type: news

Tobacco Use Accounts For 40% of All Cancers Diagnosed in US
Smoking can cause cancers of the mouth and throat, lungs, voice box, esophagus, stomach, kidney, pancreas, liver, bladder, cervix, colon and rectum, and acute myeloid leukemia (Source: Disabled World)
Source: Disabled World - November 13, 2016 Category: Disability Tags: Cancer and Tumors Source Type: news

CDC: 40% of Cancer Cases in US Might Be Linked to Tobacco
By Stacy Simon New data from the Centers for Disease Control and Prevention (CDC) show that 40% of cancers diagnosed in the US may have a link to tobacco use. The report was published in the November 11, 2016 issue of Vital Signs. Tobacco use is the leading preventable cause of cancer and cancer deaths. It can cause cancer of the liver, colon and rectum, lung, oral cavity, esophagus, pharynx (throat), larynx (voice box), stomach, pancreas, bladder, kidney, and cervix, and acute myeloid leukemia. According to the CDC, about 660,000 people in the US were diagnosed each year between 2009 and 2013 with a cancer related to toba...
Source: American Cancer Society :: News and Features - November 11, 2016 Category: Cancer & Oncology Tags: Smoking/Tobacco Source Type: news

Monitoring the Premalignant Potential of Barrett's Esophagus Monitoring the Premalignant Potential of Barrett's Esophagus
How can we better identify those patients with Barrett's esophagus who are at high risk of developing esophageal adenocarcinoma?Frontline Gastroenterology (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - November 11, 2016 Category: Radiology Tags: Gastroenterology Journal Article Source Type: news

Sponge on a string test could replace endoscopies
A ‘sponge on a string’ pill test can identify which people with a condition called Barrett’s esophagus have a low risk of developing esophageal cancer - sparing them uncomfortable endoscopies. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - November 11, 2016 Category: Science Source Type: news

Sponge on a string test could replace endoscopies
(Cancer Research UK) Cancer Research UK-funded scientists have discovered that a 'sponge on a string' pill test can identify which people with a condition called Barrett's esophagus have a low risk of developing esophageal cancer -- sparing them uncomfortable endoscopies. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 10, 2016 Category: Cancer & Oncology Source Type: news

After Brian Williams lost his brother to cancer, he discovered he also had a serious condition
Brian Williams from Surrey has had 15 endoscopies over 15 years. He has Barrett ’s oesophagus — a pre-cancerous condition affecting around two in every 100 people in the UK. (Source: the Mail online | Health)
Source: the Mail online | Health - November 8, 2016 Category: Consumer Health News Source Type: news

Combination Endosonography Helps Detect Lung Cancer Metastases Combination Endosonography Helps Detect Lung Cancer Metastases
Pooled data confirm that combining endobronchial endoscopy and esophageal endoscopy improves detection of mediastinal nodal metastases in non-small-cell lung cancer, according to European researchers.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - November 4, 2016 Category: Radiology Tags: Hematology-Oncology News Source Type: news

Docetaxel-Based Chemo Promising in Stomach and Esophageal Cancer Docetaxel-Based Chemo Promising in Stomach and Esophageal Cancer
Perioperative treatment with docetaxel-based triplet chemotherapy may beat anthracycline-based triplet chemotherapy in resectable gastric or gastro-esophageal junction adenocarcinoma, according to a randomized clinical trial.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - November 3, 2016 Category: Surgery Tags: Hematology-Oncology News Source Type: news

[Perspective] How tobacco smoke changes the (epi)genome
Worldwide, more than 1 billion people are tobacco smokers. Cigarette smoking drastically increases the risk of lung cancer. However, many other cancer types also occur more frequently in smokers than in nonsmokers, including cancers of the oral cavity, larynx, pharynx, esophagus, liver, cervix, pancreas, bladder, and kidney. Genome sequencing efforts are beginning to provide more sophisticated clues as to the processes at work that are shaping the mutational landscape of tumors. On page 618 of this issue, Alexandrov et al. (1) focused specifically on smoking-associated cancers and dissected genetic and epigenetic differenc...
Source: ScienceNOW - November 3, 2016 Category: Science Authors: Gerd P. Pfeifer Tags: Cancer Source Type: news

MassDevice.com +5 | The top 5 medtech stories for November 3, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Incoming Getinge CEO Perjos has industrial background Swedish medical technology firm Getinge said today that it found a new CEO, sending up its battered shares, but some analysts said the incoming industrialist lacked the nece...
Source: Mass Device - November 3, 2016 Category: Medical Equipment Authors: MassDevice Tags: Blog Plus 5 Source Type: news

Boston Scientific buys LumenR ’ s tissue retractor
Boston Scientific (NYSE:BSX) said today that it paid an unspecified amount for a tissue retractor developed by LumenR for endoscopic resection of the gastrointestinal tract. The Newark, Calif.-based company’s device is designed to improve endoscopic sub-mucosal dissection and mucosal resection procedures to remove pre-cancerous lesions and malignant tumors in the colon, esophagus and stomach. The LumenR device also features what Boston Scientific called “enhanced visualization” of GI tract lesions. “We are excited about the potential of the LumenR system to improve visibilit...
Source: Mass Device - November 3, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Endoscopic / Arthroscopic Mergers & Acquisitions Wall Street Beat Boston Scientific LumenR Source Type: news

Heartburn could cause CANCER: Acid reflux can damage cells in oesophagus
HEARTBURN - which occurs when acid from the stomach leaks in to the gullet - is a common condition but experts believe it could cause oesophageal cancer. (Source: Daily Express - Health)
Source: Daily Express - Health - October 31, 2016 Category: Consumer Health News Source Type: news

Report: Voice box prostheses may only last three months
(Reuters) – Tracheoesophageal voice prosthetic devices often last less than 3 months before they need to be replaced, which is a shorter lifespan than previously reported, according to a new study. “In an ideal setting, voice prostheses should last at least six months and even more ideally, up to one year,” said lead author Jan S. Lewin of The University of Texas MD Anderson Cancer Center in Houston. “In reality, they generally last somewhere about three months before they have to be replaced.” The silicone devices are placed in the shared wall between the trachea and the esophagus after ...
Source: Mass Device - October 6, 2016 Category: Medical Equipment Authors: MassDevice Tags: Clinical Trials Implants Otolaryngology Ear, Nose & Throat Source Type: news

7 Reasons To Get Outside NOW
"Nature is not a place to visit. It is home." -- Gary Snyder One of the main ways in which I know how to get back to being -- to feel connected and happy -- is to be outside in nature. If you know me at all by now, you also know that getting outside is one of my favorite means of practicing exquisite self-care. If you've been waiting for a little motivation to get out the door, here are seven great reasons to get outside NOW! 1. Reset Priorities Quiet moments of wonder and awe are a strong reminder that the purpose of life is not work. We work to support the kind of life we want to live, not the other way arou...
Source: Healthy Living - The Huffington Post - October 4, 2016 Category: Consumer Health News Source Type: news

National Oesophago-Gastric Cancer Audit 2016
This report aims to give an overall picture of the care provided to patients with oesophago-gastric cancer or oesophageal HGD by NHS services. It provides information on the: management of patients with HGD of the oesophagus; routes to diagnosis for OG cancer patients, and their staging investigations; treatment planning for OG cancer patients; patterns of curative surgery, admissions to intensive care, and short-term outcomes; use of radiotherapy in palliative treatment; and longer term survival after diagnosis with oesophago-gastric cancer. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 30, 2016 Category: Consumer Health News Source Type: news

Apple a day cuts chance of five types of cancer
A review of more than 40 previous studies by Italian experts found the biggest benefits were seen in cancer of the stomach and oesophagus, where apples nearly halved tumour risk. (Source: the Mail online | Health)
Source: the Mail online | Health - September 29, 2016 Category: Consumer Health News Source Type: news

September Is Childhood Obesity Month -- Get The Facts
The obesity epidemic continues to dominate headlines--and for good reason. Obesity is a leading cause of heart disease, diabetes, high blood pressure, and stroke. Many of these conditions occur in adults but often begin in childhood. This September is National Childhood Obesity Awareness Month. By knowing the facts and taking steps to help your children live a healthier lifestyle, childhood obesity and its resulting complications may be prevented. The Facts According to the Centers for Disease Control & Prevention (CDC), one in three children in the U.S. is overweight or obese. Childhood obesity doubled in children ...
Source: Healthy Living - The Huffington Post - September 28, 2016 Category: Consumer Health News Source Type: news